Viewing StudyNCT00060489



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00060489
Status: COMPLETED
Last Update Posted: 2011-01-26
First Post: 2003-05-06

Brief Title: Safety and Efficacy Trial of the Use of Quetiapine Fumarate SEROQUEL in the Treatment of Patients With Bipolar Depression
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Depression Bipolar
Bipolar Disorder
Keywords:
Name View
Bipolar Depression View